← FDA Drug Approvals (Drugs@FDA)

TERBUTALINE SULFATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TWI PHARMS · Approved 2020-06-19

Drug application

FDA Application #

ANDA211832

Application type

Abbreviated New Drug Application (Generic)

Brand name

TERBUTALINE SULFATE

Generic name

TERBUTALINE SULFATE

Active ingredients

TERBUTALINE SULFATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

TWI PHARMS

Manufacturer

Upsher-Smith Laboratories, LLC

First approval

2020-06-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown